DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

118.90 1.16 (0.99%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $118.90 0.99%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $117.25
Previous Close $117.74
Daily Range $116.76 - $124.35
52-Week Range $59.79 - $124.35
Market Cap $28.6B
P/E Ratio -59.46
Dividend (Yield) $0.00 (0.0%)
Volume 6,125,505
Average Daily Volume 1,427,333
Current FY EPS -$2.93

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

Top Healthcare Stocks for 2014

These 10 stocks were the top large-cap performers in healthcare during 2014.

Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Why Gilead Sciences and AbbVie Care About This Tiny Company

Achillion Pharmaceuticals is conducting a study that could reduce hepatitis C treatment to six weeks.

Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data - Analyst Blog

S&P 500 Movers: NBR, CELG

Nasdaq 100 Movers: VIP, CELG

Time to Buy This Dip in Gilead Sciences, Inc. Stock?

Shares of Gilead Sciences have slipped over the last month. Is now the time to buy this top biotech?

Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study -

Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog

Stock Market News for December 03, 2014 - Market News

See More VRTX News...

VRTX's Top Competitors

VRTX $118.90 (0.99%)
Current stock: VRTX
AMGN $170.17 (1.00%)
Current stock: AMGN
GILD $108.45 (2.76%)
Current stock: GILD
BIIB $360.67 (1.97%)
Current stock: BIIB